Evidence map›Paper›PMID 31955361›Full record

ArticleAIDS and behavior2020

Understanding Demand for PrEP and Early Experiences of PrEP Use Among Young Adults in Rural Kenya and Uganda: A Qualitative Study.

Carol S Camlin, Catherine A Koss, Monica Getahun, Lawrence Owino, Harriet Itiakorit, Cecilia Akatukwasa, Irene Maeri, Robert Bakanoma, Anjeline Onyango, Frederick Atwine and 13 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in AIDS and behavior, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01864603 (Sustainable East Africa Research in Community Health), which is not on this map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
1.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01864603 nacompletednot on this map

Sustainable East Africa Research in Community Health

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2021Enrolled150,395ConditionsHIV, Tuberculosis, Hypertension, DiabetesArmsUniversal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing
3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 110 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 3 countries.

Carol S CamlinDepartment of Obstetrics, Gynecology & Reproductive Sciences, ANSIRH Program, University of California San Francisco, 1330 Broadway, Suite 1100, Oakland, CA, 94612, USA. carol.camlin@ucsf.edu.ORCID http://orcid.org/0000-0001-5615-1164
Catherine A KossDepartment of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, USA.
Monica GetahunDepartment of Obstetrics, Gynecology & Reproductive Sciences, ANSIRH Program, University of California San Francisco, 1330 Broadway, Suite 1100, Oakland, CA, 94612, USA.
Lawrence OwinoKenya Medical Research Institute, Nairobi, Kenya.
Harriet ItiakoritInfectious Diseases Research Collaboration, Kampala, Uganda.
Cecilia AkatukwasaInfectious Diseases Research Collaboration, Kampala, Uganda.
Irene MaeriKenya Medical Research Institute, Nairobi, Kenya.
Robert BakanomaInfectious Diseases Research Collaboration, Kampala, Uganda.
Anjeline OnyangoKenya Medical Research Institute, Nairobi, Kenya.
Frederick AtwineInfectious Diseases Research Collaboration, Kampala, Uganda.
James AyiekoKenya Medical Research Institute, Nairobi, Kenya.
Jane KabamiInfectious Diseases Research Collaboration, Kampala, Uganda.
Florence MwangwaInfectious Diseases Research Collaboration, Kampala, Uganda.
Mucunguzi AtukundaInfectious Diseases Research Collaboration, Kampala, Uganda.
Asiphas OwaraganiseInfectious Diseases Research Collaboration, Kampala, Uganda.
Dalsone KwarisiimaInfectious Diseases Research Collaboration, Kampala, Uganda.
Norton SangKenya Medical Research Institute, Nairobi, Kenya.
Elizabeth A BukusiKenya Medical Research Institute, Nairobi, Kenya.
Moses R KamyaInfectious Diseases Research Collaboration, Kampala, Uganda.
Maya L PetersenGraduate Group in Biostatistics, School of Public Health, University of California Berkeley, Berkeley, USA.
Craig R CohenDepartment of Obstetrics, Gynecology & Reproductive Sciences, ANSIRH Program, University of California San Francisco, 1330 Broadway, Suite 1100, Oakland, CA, 94612, USA.
Edwin D CharleboisDepartment of Medicine, Center for AIDS Prevention Studies, University of California San Francisco, San Francisco, USA.
Diane V HavlirDepartment of Medicine, Division of HIV, Infectious Diseases, and Global Medicine, University of California San Francisco, San Francisco, USA.
Infectious Diseases Research Collaboration · UGKenya Medical Research Institute · KEUniversity of California, San Francisco · USUniversity of California, Berkeley · US

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Optimizing Adherence to PrEP among Young African Women through a Community Adherence Club InterventionK23MH114760 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOSS, CATHERINE ANNE STIMETS · 2018 to 2021
$796k
NIAID NIH HHS UM1 AI068636NIH HHS K23 MH114760NIH HHS UM1AI068636NIMH NIH HHS K23 MH114760U.S. President's Emergency Plan for AIDS Relief [NA]
6 · The paper itself

Abstract

Few studies have sought to understand factors influencing uptake and continuation of pre-exposure prophylaxis (PrEP) among young adults in sub-Saharan Africa in the context of population-based delivery of open-label PrEP. To address this gap, this qualitative study was implemented within the SEARCH study (NCT#01864603) in Kenya and Uganda, which achieved near-universal HIV testing, and offered PrEP in 16 intervention communities beginning in 2016-2017. Focus group discussions (8 groups, n = 88 participants) and in-depth interviews (n = 23) with young adults who initiated or declined PrEP were conducted in five communities, to explore PrEP-related beliefs and attitudes, HIV risk perceptions, motivations for uptake and continuation, and experiences. Grounded theoretical methods were used to analyze data. Young people felt personally vulnerable to HIV, but perceived the severity of HIV to be low, due to the success of antiretroviral therapy (ART): daily pill-taking was more threatening than the disease itself. Motivations for PrEP were highly gendered: young men viewed PrEP as a vehicle for safely pursuing multiple partners, while young women saw PrEP as a means to control risks in the context of engagement in transactional sex and limited agency to negotiate condom use and partner testing. Rumors, HIV/ART-related stigma, and desire for "proof" of efficacy militated against uptake, and many women required partners' permission to take PrEP. Uptake was motivated by high perceived HIV risk, and beliefs that PrEP use supported life goals. PrEP was often discontinued due to dissolution of partnerships/changing risk, unsupportive partners/peers, or early side effects/pill burden. Despite high perceived risks and interest, PrEP was received with moral ambivalence because of its associations with HIV/ART and stigmatized behaviors. Delivery models that promote youth access, frame messaging on wellness and goals, and foster partner and peer support, may facilitate uptake among young people.

Indexed as

AdolescentAnti-HIV AgentsFemaleFocus GroupsHIV InfectionsHumansKenyaMalePre-Exposure ProphylaxisQualitative ResearchUgandaYoung AdultAnti-HIV AgentsAdolescentsHIV preventionPre-exposure prophylaxis (PrEP)Sub-Saharan africaYouth

Identifiers

PMID31955361
PMCPMC7909847
OpenAlexW3000149191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.